These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 8390263

  • 1. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM, Barnes NM.
    Biochem Pharmacol; 1993 May 25; 45(10):2155-8. PubMed ID: 8390263
    [Abstract] [Full Text] [Related]

  • 2. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
    Barnes JM, Barnes NM, Costall B, Jagger SM, Naylor RJ, Robertson DW, Roe SY.
    Br J Pharmacol; 1992 Feb 25; 105(2):500-4. PubMed ID: 1559139
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA, Wong EH, Loury DN, Stefanich E, Michel AD, Eglen RM, Whiting RL.
    Br J Pharmacol; 1991 Apr 25; 102(4):919-25. PubMed ID: 1830236
    [Abstract] [Full Text] [Related]

  • 4. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ, Levy JC, Nielsen M, Hamon M, Gozlan H.
    Eur J Pharmacol; 1993 Sep 15; 247(1):45-56. PubMed ID: 8258360
    [Abstract] [Full Text] [Related]

  • 5. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
    Miquel MC, Emerit MB, Bolaños FJ, Schechter LE, Gozlan H, Hamon M.
    J Neurochem; 1990 Nov 15; 55(5):1526-36. PubMed ID: 2213008
    [Abstract] [Full Text] [Related]

  • 6. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
    Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Nov 15; 29(11):1037-45. PubMed ID: 2087255
    [Abstract] [Full Text] [Related]

  • 7. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
    Steward LJ, Ge J, Bentley KR, Barber PC, Hope AG, Lambert JJ, Peters JA, Blackburn TP, Barnes NM.
    Br J Pharmacol; 1995 Sep 15; 116(2):1781-8. PubMed ID: 8528560
    [Abstract] [Full Text] [Related]

  • 8. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
    Steward LJ, West KE, Kilpatrick GJ, Barnes NM.
    Eur J Pharmacol; 1993 Oct 12; 243(1):13-8. PubMed ID: 8253120
    [Abstract] [Full Text] [Related]

  • 9. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
    Wong EH, Bonhaus DW, Wu I, Stefanich E, Eglen RM.
    J Neurochem; 1993 Mar 12; 60(3):921-30. PubMed ID: 8436978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
    Gordon JC, Barefoot DS, Sarbin NS, Pinkus LM.
    J Pharmacol Exp Ther; 1989 Dec 12; 251(3):962-8. PubMed ID: 2600824
    [Abstract] [Full Text] [Related]

  • 14. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH, Clark R, Leung E, Loury D, Bonhaus DW, Jakeman L, Parnes H, Whiting RL, Eglen RM.
    Br J Pharmacol; 1995 Feb 12; 114(4):851-9. PubMed ID: 7773546
    [Abstract] [Full Text] [Related]

  • 15. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM, Costall B, Naylor RJ.
    J Pharm Pharmacol; 1988 Aug 12; 40(8):548-51. PubMed ID: 2907008
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR, Mawe GM, Branchek TA, Gershon MD.
    Am J Physiol; 1991 Jan 12; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [Abstract] [Full Text] [Related]

  • 18. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J, Barnes JM, Towers P, Barnes NM.
    Eur J Pharmacol; 1997 Aug 13; 332(3):307-12. PubMed ID: 9300265
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.